Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine if a subcutaneous dosing schedule of veltuzumab can be established in NHL or CLL paitent and to confirm safety and efficacy of veltuzumab that was previously established when administered intravenously.
Critère d'inclusion
- Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia